Amrize AG (SWX:AMRZ)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 18.34B -15.8% |
| Revenue (ttm) | 10.23B +3.5% |
| Net Income | 1.04B +8.3% |
| EPS | 1.89 +9.1% |
| Shares Out | 532.39M |
| PE Ratio | 18.19 |
| Forward PE | 15.66 |
| Dividend | 0.36 (1.05%) |
| Ex-Dividend Date | Nov 10, 2026 |
| Volume | 918,184 |
| Open | 35.27 |
| Previous Close | 35.07 |
| Day's Range | 34.26 - 35.38 |
| 52-Week Range | 29.85 - 51.34 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 39.96 (+15.99%) |
| Earnings Date | Oct 28, 2026 |
About Amrize AG
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coating... [Read more]
Financial Performance
In 2025, Amrize AG's revenue was $11.82 billion, an increase of 0.95% compared to the previous year's $11.70 billion. Earnings were $1.19 billion, a decrease of -6.99%.
Financial numbers in USD Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for AMRZ stock is "Buy." The 12-month stock price target is CHF 39.96, which is an increase of 15.99% from the latest price.
News
Amrize downgraded to Hold from Buy at Berenberg
Berenberg downgraded Amrize (AMRZ) to Hold from Buy with a price target of $46, down from $48. The firm cut the company’s estimates, saying it had a challenging year in…
Amrize Expands ‘Made in Canada' Cement Label for Canadian Builders
TORONTO--(BUSINESS WIRE)--Amrize is launching its ‘Made in Canada' label across its domestic cement manufacturing network, offering builders the assurance of Canadian-made manufacturing and quality, s...
Amrize price target lowered to $52 from $55 at Oppenheimer
Oppenheimer lowered the firm’s price target on Amrize (AMRZ) to $52 from $55 and keeps an Outperform rating on the shares following quarterly results. The firm notes that given year-to-date…
Amrize price target lowered to $52 from $54 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Amrize (AMRZ) to $52 from $54 and keeps an Overweight rating on the shares. High-quality cement assets are obscured by weaker roofing…
Amrize price target raised to $43 from $40 at DA Davidson
DA Davidson raised the firm’s price target on Amrize (AMRZ) to $43 from $40 and keeps a Neutral rating on the shares. The company delivered a mixed Q3, with a…
What Amrize (AMRZ) Said on Its Q3 Earnings Call
Amrize NYSE: AMRZ reported third-quarter revenue growth of 2.2% as pricing gains and acquisitions offset weather-related volume pressure across construction markets. Net income rose 3.3% to $558 milli...
Amrize: 3 Key Takeaways for Long-Term Investors
Pricing discipline and targeted acquisitions are offsetting cost inflation while an internal savings program delivers $73 million in year-to-date results.
Amrize (AMRZ) Q3 2026 Earnings Call Transcript
Pricing gains offset weather headwinds as margins expand in building materials.
Amrize AG Earnings Call Transcript: Q3 2026
Q3 growth was supported by pricing and acquisitions despite weather-related volume pressure and cost inflation. FY2026 revenue and EBITDA guidance was updated, with Building Materials expected price-over-cost positive in Q4 and Building Envelope recovery targeted for 2027.
Amrize AG Earnings release: Q3 2026
Amrize AG released its Q3 2026 earnings on October 29, 2026, summarizing the period's financial results.
Amrize AG Slides: Q3 2026
Amrize AG has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 29, 2026.
Amrize AG Quarterly report: Q3 2026
Amrize AG has published its Q3 2026 quarterly earnings report on October 29, 2026.
Amrize sees FY26 revenue $12.2B-$12.4B, consensus $12.51B
Amrize (AMRZ) is updating its FY26 financial guidance to included adjusted EBITDA of $2.95B-$3.05B. The company’s 2026 financial guidance now includes the assumption of capital expenditures of about $...
Amrize completes $1B share repurchase program
Amrize (AMRZ) announced that it has successfully completed its $1B share repurchase program, initiated on May 6. “Through the program, Amrize repurchased 22,446,667 shares, which is equivalent to 3.96...
Amrize Reports Third Quarter 2026 Results
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) announced today its third quarter 2026 financial results. Jan Jenisch, Chairman and CEO: "With the strength of our network and strategic foot...
Amrize Completes $1 Billion Share Repurchase Program
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize Ltd (AMRZ) announced today that it has successfully completed its $1 billion share repurchase program, initiated on May 6, 2026.Through the program,...
Amrize price target lowered to $40 from $55 at Barclays
Barclays analyst Adam Seiden lowered the firm’s price target on Amrize (AMRZ) to $40 from $55 and keeps an Equal Weight rating on the shares. The firm adjusted targets in…
Amrize Announces Date for Third Quarter 2026 Financial Results
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) will release its third quarter 2026 financial results after the U.S. market closes on Wednesday, October 28, 2026, followed by a live webcast...
Amrize price target lowered to $48 from $52 at JPMorgan
JPMorgan analyst Elodie Rall lowered the firm’s price target on Amrize (AMRZ) to $48 from $52 and keeps a Neutral rating on the shares. The firm adjusted targets in the…
Amrize initiated with a Buy at Longbow
Longbow initiated coverage of Amrize (AMRZ) with a Buy rating and $48 price target
Amrize price target lowered to $32 from $48 at RBC Capital
RBC Capital analyst Anthony Codling lowered the firm’s price target on Amrize (AMRZ) to $32 from $48 and keeps an Underperform rating on the shares. The firm adjusted ratings and…
Amrize price target lowered to $35 from $48 at Truist
Truist lowered the firm’s price target on Amrize (AMRZ) to $35 from $48 and keeps a Hold rating on the shares as part of a broader research note on Construction…
Amrize price target lowered to $40 from $44 at Wells Fargo
Wells Fargo lowered the firm’s price target on Amrize (AMRZ) to $40 from $44 and keeps an Equal Weight rating on the shares. Discussing the Building Materials sector, the firm…
Amrize price target lowered to $50 from $58 at Citi
Citi lowered the firm’s price target on Amrize (AMRZ) to $50 from $58 and keeps a Buy rating on the shares. The firm adjusted targets in the construction materials space…
Amrize initiated with an Equal Weight at Barclays
Barclays analyst Adam Seiden initiated coverage of Amrize (AMRZ) with an Equal Weight rating and $55 price target The firm views the company’s portfolio as less favorable than CRH’s while…